Update on Newly FDA-Approved Drug, Resmetirom: A Practical Perspective

1UNC Liver Center, Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC 2Department of Public Health Sciences, Pennsylvania State University, Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA 3Liver Center, Pennsylvania State University, Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA 4Cancer Institute, Pennsylvania State University, Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA 5Fatty Liver Program, Pennsylvania State University, Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA aCorresponding Author: A. Sidney Barritt IV, MD, MSCR, FACG, FAASLD, Professor of Medicine, Division of Gastroenterology and Hepatology, The University of North Carolina at Chapel Hill, 8004 Burnett Womack, CB #7584, Chapel Hill, NC, 27599-7584, Phone (919) 966-2516.